Samsung Biologics
207940.KS
#399
Rank
โ‚ฌ47.36 B
Marketcap
665,54ย โ‚ฌ
Share price
0.90%
Change (1 day)
28.45%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2024 (TTM): โ‚ฌ1.11 Billion

According to Samsung Biologics 's latest financial reports the company's current earnings are โ‚ฌ3.13 Billion. In 2023 the company made an earning of โ‚ฌ0.84 Billion, an increase over its 2022 earnings that were of โ‚ฌ0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ1.11 B32.42%
2023 โ‚ฌ0.84 B9.77%
2022 โ‚ฌ0.77 B67.66%
2021 โ‚ฌ0.45 B103.97%
2020 โ‚ฌ0.22 B57.39%
2019 โ‚ฌ0.14 B-45.46%
2018 โ‚ฌ0.26 B-390%
2017 -โ‚ฌ90.47 Million-46.74%
2016 -โ‚ฌ0.17 Billion